IDO2: Indoleamine 2,3-Dioxygenase 2

A key immunomodulatory enzyme in tryptophan catabolism and immune tolerance

Gene Information Card

Symbol IDO2
Full Name Indoleamine 2,3-Dioxygenase 2
Gene Type Protein coding
Chromosomal Location 8p11.21
NCBI Gene ID 169355 ncbi.nlm.nih.gov/gene/169355
Ensembl ID ENSG00000188676
UniProt ID Q6ZQW0
OMIM ID 612129
HGNC ID 27276
Aliases INDOL1, IDO-2, indoleamine-pyrrole 2,3-dioxygenase-like 1

Description

IDO2 encodes indoleamine 2,3-dioxygenase 2, a heme-containing enzyme that catalyzes the first and rate-limiting step in the kynurenine pathway of tryptophan catabolism. It converts L-tryptophan to N-formylkynurenine. IDO2 is expressed in antigen-presenting cells and plays a role in immune regulation, T-cell suppression, and establishing peripheral immune tolerance. It is implicated in cancer immune evasion, autoimmune diseases, and chronic inflammatory conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various) IDO2 expression in tumors promotes immune escape by depleting tryptophan and producing kynurenines that suppress T-cell activity PMID: 17671174; COSMIC
Rheumatoid arthritis Elevated IDO2 activity in synovial tissue contributes to local tryptophan depletion and immune dysregulation PMID: 21931327
Alzheimer's disease Upregulation of IDO2 in brain regions may contribute to neuroinflammation via kynurenine pathway metabolites PMID: 20074504
Systemic lupus erythematosus IDO2 polymorphisms associated with altered tryptophan metabolism and disease susceptibility PMID: 21931327

Expression Profile

Tissue Expression
Tissue nTPM level
Kidney 3.2 Low
Liver 2.1 Low
Lung 1.5 Low
Spleen 1.8 Low
Placenta 4.5 Medium
Brain 1.0 Low
Small intestine 2.0 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 0.8 Low expression
HeLa 1.2 Low expression
THP-1 2.5 Moderate expression after IFN-γ stimulation
Jurkat 0.5 Very low expression
HepG2 1.0 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
R248W Missense Rare Reduced catalytic activity; associated with altered immune regulation
Y359X Nonsense Rare Loss of function; truncated protein
V359I Missense Common (SNP rs10109853) Reduced enzyme activity; linked to autoimmune disease susceptibility
Mutation functional classification

Loss of Function (LOF)

R248W and Y359X mutations reduce or abolish IDO2 enzymatic activity, impairing tryptophan catabolism and immune suppression.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in IDO2.

Dominant Negative (DN)

No dominant-negative mutations described for IDO2.

Pathways

Kynurenine pathway (tryptophan degradation)
Tryptophan metabolism (KEGG: hsa00380)
Immune regulation via tryptophan catabolism

Protein Summary

IDO2 is a 420-amino acid heme-dependent dioxygenase that catalyzes the conversion of L-tryptophan to N-formylkynurenine. It shares structural homology with IDO1 but has distinct substrate specificity and lower catalytic efficiency. IDO2 is expressed primarily in antigen-presenting cells and is induced by inflammatory stimuli such as IFN-γ. It contributes to immune tolerance by depleting tryptophan and generating kynurenines that suppress effector T cells and promote regulatory T cell differentiation. Dysregulation of IDO2 is implicated in cancer immune evasion, autoimmune diseases, and chronic inflammation.

Related Products

Product name Cat.No. Species Gene ID
IDO2 Knockout HEK293 Cell Line EDJ-KQ2939 Human 169355 Details Get a Quote
IDO2 Knockout HeLa Cell Line EDJ-KQ58923 Human 169355 Details Get a Quote
IDO2 Knockout A-549 Cell Line EDJ-KQ67411 Human 169355 Details Get a Quote
IDO2 Knockout HCT 116 Cell Line EDJ-KQ75805 Human 169355 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: